BackAmeriprise Financial Overview

Ameriprise Financial Total Liabilities

Track Ameriprise Financial's total liabilities ($190B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$191.50B
6077.58% YoYΔ $188.41B vs prior year quarter

Peer average

Loading

Ameriprise Financial Total Liabilities History

Loading

Ameriprise Financial vs. peers: Total Liabilities Comparison

Loading

Ameriprise Financial Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Ameriprise Financial (AMP) FAQ

Ameriprise Financial posts a total liabilities of $190B as of June 2026. That compares with $3.1B in the prior-year period — up 6077.6% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Ameriprise Financial's total liabilities was $3.1B. The latest reading is $190B — a 6077.6% year-over-year increase (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Total Liabilities is one piece of Ameriprise Financial's financial statement story. At $190B, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for AMP's total liabilities usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Ameriprise Financial's other metric pages and overview cover the third.

Judging Ameriprise Financial against Finance peers is usually better than using a market-wide rule of thumb. Business models inside Finance are more comparable, which makes gaps in total liabilities easier to interpret. Start with $190B here, then scan peer and history charts to see if the gap is persistent.